Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism

Annals of Clinical Biochemistry

Volumn 40, Issue 1, 2003, Pages 16-24

  Moolenaar, S H ^a   Engelke, U F H ^a   Wevers, R A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BODY FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL CHEMISTRY; DERIVATIZATION; DIAGNOSTIC PROCEDURE; EXTRACTION; HUMAN; INBORN ERROR OF METABOLISM; METABOLIC DISORDER; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SAMPLE; SERUM; URINALYSIS;

BIOCHEMISTRY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLIC DISEASES; MODELS, CHEMICAL; SENSITIVITY AND SPECIFICITY;

EID: 0037225665     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456303321016132     Document Type: Review

References (71)

1. Iles RA, Hind AJ, Chalmers RA. Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias. Clin Chem 1985; 31: 1795-1801
2. Yamaguchi S, Koda N, Eto Y, Aoki K. Quick screening and diagnosis of organic acidemia by NMR urinalysis. J Pediatr 1985; 106: 620-2
3. Harris RK. Nuclear Magnetic Resonance Spectroscopy. A Physicochemical View. New York: Longman Scientific and Technical, 1986: 11-27
4. Homans SW. A Dictionary of Concepts in NMR. Oxford: Clarendon Press, 1989: 34-7
5. Friebolin H. Basic One- and Two-dimensional NMR Spectroscopy. Weinheim: VCH Verlagsgesellschaft, 1993: 41-107, 161-77
6. Gadian DG. NMR and Its Applications to Living Systems. New York: Oxford University Press, 1995
7. Pretsch E, Seibl J, Simon W, Clerc T. Spectral Data for Structure Determination of Organic Compounds. Berlin: Springer-Verlag, 1989
8. Fan WMT. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog NMR Spectrosc 1996; 28: 161-219
9. Lindon JC, Nicholson JK, Everett JR. NMR spectroscopy of biofluids. Annu Rep NMR Spectrosc 1999; 38: 1-88
10. 1H-FT-NMR spectrometry. Eur J Pediatr 1986; 145: 260-6
11. Bock JL. Analysis of serum by high-field proton nuclear magnetic resonance. Clin Chem 1982; 28: 1873-7
12. 1H n.m.r. studies of vertebrate blood and plasma. Biochem J 1983; 211: 605-15
13. Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH. Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J 1984; 217: 365-75
14. Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ. Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem 1984; 30: 426-32
15. Bales JR, Sadler PJ, Nicholson JK, Timbrell JA. Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy. Clin Chem 1984; 30: 1631-6
16. Iles RA, Jago JR, Williams SR, Chalmers RA. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency studied using 2-dimensional proton nuclear magnetic resonance spectroscopy. FEBS Lett 1986; 203: 49-53
17. Yamaguchi S, Koda N, Ohashi T. Diagnosis of alkaptonuria by NMR urinalysis: Rapid qualitative and quantitative analysis of homogentisic acid. Tohoku J Exp Med 1986; 150: 227-8
18. Petroff OA, Yu RK, Ogino T. High-resolution proton magnetic resonance analysis of human cerebrospinal fluid. J Neurochem 1986; 47: 1270-6
19. Bell JD, Brown JC, Sadler PJ, Macleod AF, Sonksen PH, Hughes RD, et al. High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid. Clin Sci 1987; 72: 563-70
20. 1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient. NMR Biomed 1991; 4: 192-200
21. Kriat M, Nicoli F, Vion DJ, Confort GS, Dano P, Grisoli F, et al. High resolution NMR spectroscopy of CSF: Methodological issues and perspective clinical applications. Ann Biol Clin Paris 1991; 49: 461-7
22. Lynch J, Peeling J, Auty A, Sutherland GR. Nuclear magnetic resonance study of cerebrospinal fluid from patients with multiple sclerosis. Can J Neurol Sci 1993; 20: 194-8
23. 1H-NMR spectroscopy of human cerebrospinal fluid: Effects of sample manipulation and assignment of resonances. J Pharm Biomed Anal 1993; 11: 651-64
24. 1H-NMR spectroscopy of cerebrospinal fluid in spinal diseases. Neurosurg Rev 1993; 16: 307-15
25. Nicoli F, Vion DJ, Maloteaux JM, Delwaide C, Confort GS, Sciaky M, et al. CSF and serum metabolic profile of patients with Huntington's chorea: A study by high resolution proton NMR spectroscopy and HPLC. Neurosci Lett 1993; 154: 47-51
26. Videen JS, Ross BD. Proton nuclear magnetic resonance urinalysis: Coming of age. Kidney Int Suppl 1994; 47: S122-8
27. Moolenaar SH. Body Fluid NMR Spectroscopy in the Diagnosis of Inborn Errors of Metabolism. PhD Thesis. Nijmegen, The Netherlands, 2001
28. 1H-NMR Spectroscopy in Inborn Errors of Metabolism. Heilbronn: SPS Publications, 2002
29. 1H-NMR spectroscopy. Clin Chim Acta 1992; 209: 47-60
30. 1H-NMR spectroscopy. Clin Chim Acta 1993; 221: 1-13
31. 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal Biochem 1994; 220: 284-96
32. 1H NMR spectroscopic analysis of urine. J Inherit Metab Dis 1999; 22: 297-301
33. Lehnert W, Stogmann W, Engelke U, Wevers RA, van-den-Berg GB. Long-term follow up of a new case of hawkinsinuria. Eur J Pediatr 1999; 158: 578-82
34. Yamaguchi S, Yamamoto H, Arai T, Ikei K, Mizukoshi R, Koda N. Screening of diseased children by NMR urine analysis. Works in Progress 10th Annual Meeting of the Society of Magnetic Resonance in Medicine 1991: 1201
35. 1H-NMR of cerebrospinal fluid. Clin Chem 1995; 41: 744-51
36. 1H NMR studies of urine from premature and sick babies. Magn Reson Med 1989; 11: 193-201
37. Burns SP, Iles RA, Ryalls M, Leonard JV. Methylgenesis from betaine in cystathionine-beta-synthase deficiency. Biochem Soc Trans 1993; 21: 455S
38. 1H NMR determination of urinary betaine in patients with premature vascular disease and mild homocysteinemia. Clin Chem 1995; 41: 275-83
39. Yamaguchi S, Koda N, Eto Y, Aoki K. Rapid screening of metabolic disease by proton NMR urinalysis. Lancet 1984; ii: 284
40. Moolenaar SH, Engelke UFH, Abeling NGGM, Mandel H, Duran M, Wevers RA. Prolidase deficiency diagnosed by H-NMR spectroscopy of urine. J Inherit Metab Dis 2001; 24: 843-50
41. Farrant RD, Walker V, Mills GA, Mellor JM, Langley GJ. Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. J Biol Chem 2001; 276: 15107-16
42. Wehrli SL, Berry GT, Palmieri M, Mazur A, Elsas L, Segal S. Urinary galactonate in patients with galactosemia: Quantitation by nuclear magnetic resonance spectroscopy. Pediatr Res 1997; 42: 855-61
43. Moolenaar SH, van der Knaap MS, Engelke UF, Pouwels PJ, Janssen-Zijlstra FS, Verhoeven NM, et al. In vivo and in vitro NMR spectroscopy reveal a putative novel inborn error involving polyol metabolism. NMR Biomed 2001; 14: 167-76
44. 1H NMR spectroscopy of cerebrospinal fluid and urine in Canavan's disease. Proceedings of the 11th Annual Meeting of the Society of Magnetic Resonance in Medicine 1992; 2: 3416
45. Burns SP, Holmes HC, Chalmers RA, Johnson A, Iles RA. Proton NMR spectroscopic analysis of multiple acyl-CoA dehydrogenase deficiency - Capacity of the choline oxidation pathway for methylation in vivo. Biochim Biophys Acta 1998; 1406: 274-82
46. 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J Pharm Biomed Anal 1997; 15: 1647-59
47. Lorek AK, Penrice JM, Cady EB, Leonard JV, Wyatt JS, Iles RA, et al. Cerebral energy metabolism in isovaleric acidaemia. Arch Dis Child Fetal Neonatal Ed 1996; 74: F211-3
48. Neild GH, Foxall PJ, Lindon JC, Holmes EC, Nicholson JK. Uroscopy in the 21st century: High-field NMR spectroscopy. Nephrol Dial Transplant 1997; 12: 404-17
49. Iles RA, Buckingham MJ, Hawkes GE. Spin-echo proton-nuclear-magnetic-resonance detection of normal and abnormal metabolites in plasma and urine. Biochem Soc Trans 1983; 11: 374-5
50. 1H-n.m.r. spectroscopic study. Biochem Soc Trans 1990; 18: 912-3
51. 1H nuclear magnetic resonance studies on urinary metabolites from patients with 2-methylacetoacetyl CoA thiolase deficiency. Clin Chim Acta 1986; 159: 153-61
52. 1H-nuclear-magnetic-resonance spectroscopy. Biochem Soc Trans 1986; 14: 731-2
53. 1H-NMR studies of urine in propionic acidemia and methylmalonic acidemia. Acta Paediatr Jpn 1991; 33: 139-45
54. Iles RA, Chalmers RA, Hind AJ. Methylmalonic aciduria and propionic acidaemia studied by proton nuclear magnetic resonance spectroscopy. Clin Chim Acta 1986; 161: 173-89
55. 1H-nuclear-magnetic-resonance spectroscopy. Biochem Soc Trans 1986; 14: 702-3
56. Iles RA, Chalmers RA. Nuclear magnetic resonance spectroscopy in the study of inborn errors of metabolism. Clin Sci 1988; 74: 1-10
57. Ghauri FYK, Parkes HG, Nicholson JK. Asymptomatic 5-oxoprolinuria detected by proton magnetic resonance spectroscopy. Clin Chem 1993; 39: 1341
58. 1H-NMR spectroscopy of blood plasma for metabolic studies. Clin Chem 1994; 40: 1245-50
59. 1H-NMR spectroscopy. Clin Chim Acta 1991; 204: 263-77
60. 1H n.m.r. spectroscopy in vitro. Biochem Soc Trans 1990; 18: 551-2
61. 1H-NMR spectroscopy of body fluids: Inborn errors of purine and pyrimidine metabolism. Clin Chem 1999; 45: 539-48
62. 1H NMR spectroscopy of body fluids in patients with inborn errors of purine and pyrimidine metabolism. J Inherit Metab Dis 1997; 20: 345-50
63. Moolenaar SH, Göhlich-Ratmann G, Engelke UF, Spraul M, Humpfer E, Dvortsak P, et al. Beta-ureidopropionase deficiency: A novel inborn error of metabolism discovered using NMR spectroscopy on urine. Magn Reson Med 2001; 46: 1014-7
64. Moolenaar SH, Poggi-Bach J, Engelke UF, Corstiaensen JM, Heerschap A, de Jong JG, et al. Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. Clin Chem 1999; 45: 459-64
65. Sewell AC, Murphy HC, Iles RA. Proton nuclear magnetic resonance spectroscopic detection of sialic acid storage disease. Clin Chem 2002; 48: 357-9
66. Abeling NG, van Gennip AH, Bakker HD, Heerschap A, Engelke U, Wevers RA. Diagnosis of a new case of trimethylaminuria using direct proton NMR spectroscopy of urine. J Inherit Metab Dis 1995; 18: 182-4
67. 1H-NMR analysis of trimethylamine in urine for the diagnosis of fish-odour syndrome. Clin Chim Acta 1997; 263: 139-46
68. 1H NMR studies on protein binding of histidine, tyrosine and phenylalanine in blood plasma. NMR Biomed 1989; 2: 77-82
69. 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data. NMR Biomed 1990; 3: 166-72
70. Gartland KPR, Beddell CR, Lindon JC, Nicholson JK. J Pharm Biomed Anal 1990; 8: 963-8
71. Gartland KP, Beddell CR, Lindon JC, Nicholson JK. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. Mol Pharmacol 1991; 39: 629-42